BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,415 | -22.7% | 6,132 | -6.7% | 0.04% | -20.4% |
| Q2 2023 | $299,319 | +11.5% | 6,570 | -0.7% | 0.05% | +2.1% |
| Q1 2023 | $268,376 | -21.8% | 6,617 | -1.7% | 0.05% | -26.2% |
| Q4 2022 | $343,219 | -4.4% | 6,734 | +0.9% | 0.06% | -13.3% |
| Q3 2022 | $359,000 | -22.0% | 6,674 | -6.8% | 0.08% | -16.7% |
| Q2 2022 | $460,000 | -18.0% | 7,158 | -1.0% | 0.09% | -5.3% |
| Q1 2022 | $561,000 | -9.7% | 7,230 | +0.0% | 0.10% | -12.8% |
| Q4 2021 | $621,000 | +8.8% | 7,229 | +1.9% | 0.11% | -1.8% |
| Q3 2021 | $571,000 | +0.4% | 7,096 | +0.3% | 0.11% | 0.0% |
| Q2 2021 | $569,000 | -1.6% | 7,072 | +3.2% | 0.11% | -11.2% |
| Q1 2021 | $578,000 | +4.7% | 6,851 | -0.4% | 0.12% | -2.3% |
| Q4 2020 | $552,000 | 0.0% | 6,877 | +0.2% | 0.13% | -14.7% |
| Q3 2020 | $552,000 | -6.1% | 6,865 | +0.5% | 0.15% | -9.1% |
| Q2 2020 | $588,000 | +3.3% | 6,833 | -2.6% | 0.16% | -16.2% |
| Q1 2020 | $569,000 | -3.7% | 7,012 | -0.7% | 0.20% | +19.4% |
| Q4 2019 | $591,000 | -4.2% | 7,063 | +0.1% | 0.16% | -12.2% |
| Q3 2019 | $617,000 | +6.7% | 7,054 | -0.0% | 0.19% | +8.0% |
| Q2 2019 | $578,000 | +13.6% | 7,057 | +12.6% | 0.17% | +9.4% |
| Q1 2019 | $509,000 | +23.5% | 6,265 | +0.0% | 0.16% | +7.4% |
| Q4 2018 | $412,000 | -18.9% | 6,264 | -5.0% | 0.15% | -5.7% |
| Q3 2018 | $508,000 | +4.3% | 6,595 | -0.0% | 0.16% | -0.6% |
| Q2 2018 | $487,000 | +13.5% | 6,596 | +0.0% | 0.16% | +11.3% |
| Q1 2018 | $429,000 | +0.7% | 6,595 | +0.0% | 0.14% | +1.4% |
| Q4 2017 | $426,000 | +1.4% | 6,594 | -1.6% | 0.14% | -4.1% |
| Q3 2017 | $420,000 | +3.7% | 6,701 | +0.0% | 0.15% | -3.3% |
| Q2 2017 | $405,000 | +66.0% | 6,699 | +42.5% | 0.15% | +55.7% |
| Q1 2017 | $244,000 | +17.3% | 4,702 | +0.0% | 0.10% | +4.3% |
| Q4 2016 | $208,000 | -6.7% | 4,700 | +0.0% | 0.09% | -9.7% |
| Q3 2016 | $223,000 | +5.2% | 4,699 | +0.0% | 0.10% | 0.0% |
| Q2 2016 | $212,000 | -35.4% | 4,698 | +0.2% | 0.10% | -41.5% |
| Q2 2015 | $328,000 | – | 4,688 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |